321 filings
Page 4 of 17
6-K
z965l70oe
2 Sep 21
BELLUS Health to Present at the H.C. Wainwright Global Investment Conference
7:00am
6-K
h9l0o5ep
23 Aug 21
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021
7:00am
6-K
duzfhtp0dtq34qj
11 Aug 21
Condensed Consolidated Interim Financial Statements of
4:43pm
6-K
cpecaebdb5v abpkc
11 Aug 21
BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights
4:31pm
6-K
0ti q0lcth77c
25 May 21
BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference
7:00am
6-K
lggzmky 1npkhwr3hfx
12 May 21
BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
7:00am
6-K
ds2qi 8fjif2d1
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
408ns9fmqp
10 May 21
BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
5f44yx3wau2b2znyms
10 May 21
BELLUS Health to Present at the American Thoracic Society 2021 International Conference
7:03am
6-K
zd5cbx33igh98y3peii3
13 Apr 21
BELLUS Health to Present at the Bloom Burton & Co. Healthcare Investor Conference
7:00am
6-K
ky9nu0 xue
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
3lt kanidjc9r6
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
6-K
c655riu58uw1huc drg
24 Mar 21
BELLUS Health Appoints William Mezzanotte, MD, MPH to its Board of Directors
7:00am
6-K
dn9qd
5 Mar 21
Report of Foreign Private Issuer for the Month of March 2021
11:43am
6-K
wljll 61s8vm
25 Feb 21
BELLUS Health Reports Year 2020 Financial Results and Business Highlights
4:02pm
6-K
7myyf4ptg 262scpkv0q
22 Feb 21
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
7:00am
6-K
v275t7kges9l vgo
14 Jan 21
Bellus Health Inc. 6-K
7:00am
6-K
gypz7wp
23 Dec 20
Open Market Sale Agreementsm
5:06pm
6-K
afj igtrutki0y9u6b
14 Dec 20
Bellus Health Inc. Form 6-K
7:01am
6-K
cgb00yf7d iq
8 Dec 20
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am